Insider

Stephen Hoge

President · Moderna, Inc. (MRNA)

sold: $28,704,958 · planned sales: $45,604,975

DateTradeSharesAvg. priceValueFiling
November 17, 2026Planned sale 10b5-1 plan39,215—$8,298,105SEC
November 16, 2026Planned sale 10b5-1 plan39,160—$8,601,863SEC
October 15, 2026Planned sale 10b5-1 plan39,145—$8,640,033SEC
October 15, 2026Sale 10b5-1 plan78,369$217.10$17,013,538SEC
October 14, 2026Planned sale 10b5-1 plan39,224—$8,373,519SEC
September 15, 2026Planned sale 10b5-1 plan40,281—$5,883,709SEC
September 15, 2026Sale 10b5-1 plan80,575$145.10$11,691,420SEC
September 14, 2026Planned sale 10b5-1 plan40,294—$5,807,746SEC

Shown: open-market purchases and sales (Form 4, codes P and S) and notices of planned sales (Form 144), values as filed. Not shown: grants, tax withholding, gifts and option exercises — they are not trades. A disclosed trade does not show how the person rates the company and is not a recommendation.